Overview
TechGen Biotech Solutions is pioneering the development of advanced drug delivery systems designed to significantly improve the effectiveness of existing medications while reducing side effects. Our patented technology encapsulates drugs within microspheres that allow for targeted release, ultimately leading to enhanced therapeutic outcomes. This innovative approach not only has the potential to transform how medications are delivered but also offers substantial savings in healthcare costs through better patient compliance and reduced hospital visits. Since our inception in 2025, we have successfully completed our initial prototype stage, securing partnerships with leading research institutions and obtaining positive preliminary trial results. With a dedicated team of experts in biochemistry and pharmacology, we are now poised to scale production and begin extensive clinical trials. We have attracted interest from several healthcare providers eager to integrate our solutions into their treatment protocols, demonstrating strong market viability. To bring our product to market, we are seeking $400,000 in investment to support the next crucial phases of our development, including fund…
Use of funds
The funds will be allocated as follows:
- Clinical Trials: $200,000
- Regulatory Compliance: $100,000
- Manufacturing Setup: $50,000
- Marketing and Outreach: $50,000
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.